Biotechnology

10 CDMO Up & Comers 2026

As one notable company exits the field, growing CDMOs open facilities and secure...

Top 10 Contract Development and Manufacturing Organizat...

A majority of biopharmas are expected to increase their reliance on CDMOs in com...

Revvity Signs Agreement to Acquire Human Cell Design

As wet-lab validation becomes increasingly important to support artificial intel...

CAR T Manufacturing in Japan Gets Boost from Teijin-Shi...

Shinshu University Hospital's expertise in CAR T-cell therapy R&D and clinical a...

Smarter Cell Culture Starts with Better Media

Advances in media optimization, cell engineering, and AI are reshaping intensifi...

Healthcare AI’s next test is integration

The entrance of major AI companies into healthcare is a meaningful and welcome d...

Microscale Chromatography Moves Toward Manufacturing Re...

AstraZeneca researchers show that automated microscale chromatography can genera...

No One-Size-Fits-All Solution for Autologous Cell Thera...

The operational challenges of making patient-specific cell therapies require car...

Increasing CHO Cell Productivity

Overexpressing the gene Pabpc1 in CHO cell cultures increases productivity by 30...

Monoclonal Antibodies Targeting MMP-9 Alleviate Periphe...

Scientists developed monoclonal antibodies targeting matrix metalloproteinase-9,...

Gene Therapy Extends Lifespan and Reduces Symptoms in S...

Intravenous gene therapy extended lifespan, reduced neurological symptoms, and i...

The Emerging Power of Mass Spectrometry in Oncology

Novel approaches are urgently needed to improve availability of diagnostic assay...

Novartis Shares Slide After Neuromuscular Candidate Acq...

Del-desiran failed the Phase III HARBOR trial (NCT06411288) by missing the study...

NRAS Mutations May Require Mutation-Guided Combination ...

Mutant NRAS has remained difficult to target in cancer. New findings suggest tha...

ADCs, mAbs, CAR Ts: One Bioluminescent Platform Measure...

The HiBiT Target Cell Killing (TCK) platform, with off-the-shelf, mix-and-match ...

The Multi-Attribute Method (MAM) as a Biologics Lifecyc...

A more coherent approach: a peptide-mapping LC-HRMS (liquid chromatography-high ...